Many conditions can benefit from HBOT treatment, some of which include: Concussion/TBI Decompression sickness Carbon monoxide poisoning Crush injuries Severe anemia Non-healing wounds (i.e., diabetic foot ulcers) Gas gangrene Severe bone or skin infections that cause necrosis (tissue death) While HBOT is considered generally safe for most people, it should be noted that there are certain instances in which HBOT is not recommended as a treatment modality
IGF-LR3 (Insulin-like Growth Factor-1 Long R3) is a recombinant analogue of IGF-1 with extended half-life
As soon as the catalytic mechanism of GPx was discovered, the design and development of synthetic compounds mimicking GPx-like activity became an active research area [71,72,73]
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours
...ALLISON and her team will always be in my heart and TASHA and LUNIE are
Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, et al: Extension of life-span with superoxide dismutase = catalase mimetics
